An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia
Clinical trial NCT06337474 · RECRUITING
Trial details
- NCT number
- NCT06337474
- Sponsor
- Changzhou No.2 People's Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-30
- Primary completion
- 2025-07-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.